11
TITLE: Social determinants of health in uterine carcinosarcoma
AUTHORS: Larissa L Aroche Gutierrez; Donald D McIntire; Jayanthi Lea; Salvatore LoCoco; David Scott Miller ;
PUBLISHED: 2024, SOURCE: Gynecologic Oncology, VOLUME: 184
INDEXED IN: Scopus CrossRef Unpaywall
12
TITLE: Adenocarcinoma of the uterine corpus and sarcomas of the uterus
AUTHORS: William T Creasman; David Scott Miller ; Ramez N Eskander; Matthew Powell;
PUBLISHED: 2023, SOURCE: DiSaia and Creasman Clinical Gynecologic Oncology
INDEXED IN: Scopus CrossRef
13
TITLE: Contributors
AUTHORS: Floor J Backes; Lindsey B Beffa; Caroline C Billingsley; Michael J Birrer; Kristin Bixel; Teresa K.L Boitano; Wendy R Brewster; Dana M Chase; Shaina Bruce; Angelena Crown; Christina S Chu; Daniel L Clarke-Pearson; Robert A Ross; Brian Crosland; Joshua G Cohen; Robert L Coleman; Paul A DiSilvestro; Oliver Dorigo; Linda R Duska; Ramez Nassef Eskander; ...More
PUBLISHED: 2023, SOURCE: DiSaia and Creasman Clinical Gynecologic Oncology
INDEXED IN: CrossRef
14
TITLE: Fertility-sparing Treatment for Early-stage Endometrial Cancer is Safe and Does Not Compromise Oncological Outcome. No
AUTHORS: Jessica E. Parker; David Scott Miller ;
PUBLISHED: 2023, SOURCE: 50 Big Debates in Gynecologic Oncology
INDEXED IN: CrossRef Unpaywall
15
TITLE: Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice  Full Text
AUTHORS: Domenica Lorusso; Nicoletta Colombo; Antonio Casado Herraez; Alessandro D Santin; Emeline Colomba; David Scott Miller ; Keiichi Fujiwara; Sandro Pignata; Sally E Baron Hay; Isabelle Laure Ray Coquard; Ronnie Shapira Frommer; Yong Man Kim; Mary McCormack; Rachid Massaad; Allison Martin Nguyen; Qi Zhao; Jodi McKenzie; Vimalanand S Prabhu; Vicky Makker;
PUBLISHED: 2023, SOURCE: European Journal of Cancer, VOLUME: 186
INDEXED IN: Scopus CrossRef: 6
16
TITLE: Isolated para-aortic nodal recurrence after treatment of early stage cervical carcinoma
AUTHORS: Steven B Holloway; Alyssa J Mercadel; David Scott Miller ; Jayanthi S Lea;
PUBLISHED: 2023, SOURCE: Gynecologic Oncology, VOLUME: 170
INDEXED IN: Scopus CrossRef
17
TITLE: Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Bradley J Monk; Helen MacKay; Alessandro D Santin; David Scott Miller ; Richard G Moore; Sally Baron Hay; Isabelle Ray Coquard; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva M Guerra Alia; Ulus A Sanli; Steven Bird; Robert Orlowski; Jodi McKenzie; Chinyere Okpara; Gianmaria Barresi; ...More
PUBLISHED: 2023, SOURCE: Journal of Clinical Oncology, VOLUME: 41, ISSUE: 16
INDEXED IN: Scopus CrossRef: 43
18
TITLE: Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
AUTHORS: Ignace Vergote; Jose Alejandro Pérez-Fidalgo; Erika Paige Hamilton; Giorgio Valabrega; Toon Van Gorp; Jalid Sehouli; David Cibula; Tally Levy; Stephen Welch; Debra L Richardson; Eva M Guerra; Giovanni Scambia; Stéphanie Henry; Pauline Wimberger; David Scott Miller ; Jaroslav Klat; Jerónimo Martínez-Garcia; Francesco Raspagliesi; Bhavana Pothuri; Ignacio Romero; ...More
PUBLISHED: 2023, SOURCE: Journal of Clinical Oncology, VOLUME: 41, ISSUE: 35
INDEXED IN: Scopus CrossRef: 21
19
TITLE: Pembrolizumab plus lenvatinib combination therapy for advanced endometrial carcinoma
AUTHORS: Christopher A Walker; Alexandra N Spirtos; David Scott Miller ;
PUBLISHED: 2023, SOURCE: Expert Review of Anticancer Therapy, VOLUME: 23, ISSUE: 4
INDEXED IN: Scopus CrossRef: 1
20
TITLE: Supplementary Figures 1-6 from Epigenetic Repression of <i>microRNA-129-2</i> Leads to Overexpression of <i>SOX4</i> Oncogene in Endometrial Cancer
AUTHORS: Yi-Wen Huang; Joseph C Liu; Daniel E Deatherage; Jingqin Luo; David G Mutch; Paul J Goodfellow; David Scott Miller ; Tim H-M Huang;
PUBLISHED: 2023
INDEXED IN: CrossRef
Page 2 of 30. Total results: 299.